AMIDA CARE LAUNCHES 365TRANSVISIBILITY.ORG IN HONOR OF TRANSGENDER DAY OF VISIBILITY
Published: 10 Apr 2026
Author: Towards Healthcare
Amida Care, New York’s non-profit Medicaid Special Needs Health Plan specialising in HIV care, sexual health, and gender-affirming services, announced the launch of 365TransVisibility.org, a new digital hub and permanent home for the ground-breaking bilingual campaign - Every Day Is Trans Day of Visibility.
This new website will expand the reach and longevity of the campaign by serving as the official archive for these profiles, while also sharing community stories, celebrating transgender leadership, and providing health information and resources.
According to Towards Healthcare, the U.S. Sex Reassignment Hormone Therapy Market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 1.39 billion in 2026 to approximately USD 2.61 billion by 2035, representing a compound annual growth rate (CAGR) of 7.2% from 2026 to 2035. Growth is driven by the increasing awareness and acceptance of gender affirming treatment. The expansion of the telemedicine-based hormone therapy platform has made it more accessible.
Transcending Visibility
365 Days of Collective Power, hosted by the New York Transgender Advocacy Group (NYTAG) and Amida Care, has officially launched for Transgender Day of Visibility. It is committed to advancing transgender health and equity, including Amida Care, Colectivo Intercultural TRANSgrediendo, Community Healthcare Network (CHN), Destination Tomorrow, NEW Pride Agenda, NYTAG, and TransLatina Network. These partners together launched the initiative as a bold and affirming message that trans visibility, strength, and joy are year-round.
About Amida Care
It is a Medicaid not-for-profit health plan in New York City and an expert in HIV, sexual health, and gender-affirming care. It specialises in health coverage and coordinated care to complex conditions, including HIV and behavioural health disorders, and people who are transgender or who are homeless, regardless of HIV status. It has a wide network of health care providers throughout New York City and is the largest Medicaid Special Needs Health Plan (SNP) in New York State.
A recent report by Towards Healthcare highlights that the U.S. Sex Reassignment Hormone Therapy Market is witnessing growth due to increasing awareness of transgender rights, technological advancement, and shifting social norms. An individual seeks to align their physical characteristics with their gender identity, leading to a significant increase in treatment options available.
Development of novel hormonal therapy with better efficacy, the rise in availability of long-acting injectable, transdermal system and bio-identical hormones, which have improved efficiency, safety, and convenience of hormone therapy for patients.